Erika Iwamoto1, Yutaka Yamada2, Masaki Katayose3, Rintaro Sakamoto2, Toru Neki3, Jun Sugawara4, Shigehiko Ogoh5. 1. Department of Physical Therapy, School of Health Sciences, Sapporo Medical University, Sapporo, 060-8556, Japan. e.iwamoto@sapmed.ac.jp. 2. Graduate School of Health Sciences, Sapporo Medical University, Sapporo, Japan. 3. Department of Physical Therapy, School of Health Sciences, Sapporo Medical University, Sapporo, 060-8556, Japan. 4. National Institute of Advanced Industrial Science and Technology, Tsukuba, Japan. 5. Department of Biomedical Engineering, Toyo University, Kawagoe, Japan.
Abstract
PURPOSE: This study aimed to test our hypothesis that acute hypotension attenuates brachial flow-mediated dilation (FMD) as an index of endothelial function in healthy humans. METHODS: Twelve healthy men (21.8 ± 1.6 years, body mass index; 22.2 ± 1.6 kg/m2) participated in this study. Brachial FMD was measured in three trials: standardized FMD protocol (control trial), abrupt decrease in blood pressure (BP) via thigh cuff inflation-deflation (hypotension trial) and decrease in shear rate (SR) via a shortened forearm occlusion time (SR reduction trial). Brachial diameter and blood velocity were measured using Duplex ultrasound. RESULTS: Mean arterial pressure during reactive hyperaemia showed a marked decrease in the hypotension trial (- 23.7 ± 6.0 mmHg), but not in the control and SR reduction trials. SR area under the curve was attenuated in the SR reduction trial (P < 0.001), but not in the control and hypotension trials (P = 0.316). Consequently, FMD was attenuated in the hypotension and SR reduction trials compared with that in the control trial (P = 0.003 and P = 0.043, respectively), and was attenuated to a greater extent in the hypotension trial compared with the SR reduction trial (P = 0.006; control, 6.9 ± 3.5%; hypotension, 3.5 ± 1.7%; SR reduction, 5.0 ± 2.2%). After adjusting FMD using SR, FMD remained attenuated in the hypotension trial (P = 0.014), but not in the SR reduction trial. CONCLUSION: Our findings indicate that arterial pressure as well as sympathetic nervous system activation could be an important determinant of FMD. Blunted FMD of peripheral arteries may be a rational response to restore BP and/or prevent further reduction of BP following acute hypotension in healthy humans.
PURPOSE: This study aimed to test our hypothesis that acute hypotension attenuates brachial flow-mediated dilation (FMD) as an index of endothelial function in healthy humans. METHODS: Twelve healthy men (21.8 ± 1.6 years, body mass index; 22.2 ± 1.6 kg/m2) participated in this study. Brachial FMD was measured in three trials: standardized FMD protocol (control trial), abrupt decrease in blood pressure (BP) via thigh cuff inflation-deflation (hypotension trial) and decrease in shear rate (SR) via a shortened forearm occlusion time (SR reduction trial). Brachial diameter and blood velocity were measured using Duplex ultrasound. RESULTS: Mean arterial pressure during reactive hyperaemia showed a marked decrease in the hypotension trial (- 23.7 ± 6.0 mmHg), but not in the control and SR reduction trials. SR area under the curve was attenuated in the SR reduction trial (P < 0.001), but not in the control and hypotension trials (P = 0.316). Consequently, FMD was attenuated in the hypotension and SR reduction trials compared with that in the control trial (P = 0.003 and P = 0.043, respectively), and was attenuated to a greater extent in the hypotension trial compared with the SR reduction trial (P = 0.006; control, 6.9 ± 3.5%; hypotension, 3.5 ± 1.7%; SR reduction, 5.0 ± 2.2%). After adjusting FMD using SR, FMD remained attenuated in the hypotension trial (P = 0.014), but not in the SR reduction trial. CONCLUSION: Our findings indicate that arterial pressure as well as sympathetic nervous system activation could be an important determinant of FMD. Blunted FMD of peripheral arteries may be a rational response to restore BP and/or prevent further reduction of BP following acute hypotension in healthy humans.
Authors: Lorenzo Ghiadoni; Francesco Faita; Massimo Salvetti; Carlo Cordiano; Almerina Biggi; Massimo Puato; Antonio Di Monaco; Luca De Siati; Massimo Volpe; Giuseppe Ambrosio; Vincenzo Gemignani; Maria L Muiesan; Stefano Taddei; Gaetano A Lanza; Francesco Cosentino Journal: J Hypertens Date: 2012-07 Impact factor: 4.844
Authors: Dick H J Thijssen; Mark A Black; Kyra E Pyke; Jaume Padilla; Greg Atkinson; Ryan A Harris; Beth Parker; Michael E Widlansky; Michael E Tschakovsky; Daniel J Green Journal: Am J Physiol Heart Circ Physiol Date: 2010-10-15 Impact factor: 4.733
Authors: Michel L Hijmering; Erik S G Stroes; Jobien Olijhoek; Barbara A Hutten; Peter J Blankestijn; Ton J Rabelink Journal: J Am Coll Cardiol Date: 2002-02-20 Impact factor: 24.094
Authors: Michael M Tymko; Joshua C Tremblay; Craig D Steinback; Jonathan P Moore; Alex B Hansen; Alexander Patrician; Connor A Howe; Ryan L Hoiland; Daniel J Green; Philip N Ainslie Journal: J Appl Physiol (1985) Date: 2017-08-31
Authors: Andreas H Wagner; Ocko Kautz; Kathrin Fricke; Murielle Zerr-Fouineau; Elena Demicheva; Björn Güldenzoph; Justo Lorenzo Bermejo; Thomas Korff; Markus Hecker Journal: Arterioscler Thromb Vasc Biol Date: 2009-09-03 Impact factor: 8.311
Authors: Daniel J Green; Ellen A Dawson; Hans M M Groenewoud; Helen Jones; Dick H J Thijssen Journal: Hypertension Date: 2013-11-25 Impact factor: 10.190
Authors: Takuro Washio; Benjamin S Stacey; Shigehiko Ogoh; Hayato Tsukamoto; Angelo Iannetelli; Thomas S Owens; Thomas A Calverley; Lewis Fall; Christopher J Marley; Damian M Bailey Journal: J Physiol Sci Date: 2022-07-20 Impact factor: 2.257